Use of dimiracetam in the treatment of chronic pain
EP2631657A1
Immunoassay for the detection of the 22kDa C-terminal fragment (CAF) of agrin
EP2635554A2
Novel neurotrypsin inhibitors
EP2635559A2
Neurotrypsin inhibitors
EP2658540A1
Therapeutic use of dimiracetam to prevent the hand&foot syndrome caused by sorafenib
EP2484695A1
A method for the production of hybridoma cell lines producing monoclonal antibodies capable to specifically binding to a human C44-fragment of agrin
EP2295068A1
Modified agrin-fragment capable of restoring muscle strength for use as a medicament
EA022867B1
Use of dimiracetam in the treatment of osteoarthritis and diseases associated therewith
EP2098526A1
Nitrogen-containing bicyclic compounds active on chronic pain conditions
WO2008074813A2
Optiogenin for the treatment of neural diseases
EP1990420A1
Method for the detection of the in-vivo activity of neurotrypsin, use of the method and use of the C-terminal 22-kDa fragment of agrin as biomarker in diagnosis and monitoring of neurotrypsin-related disturbances
